France warns against the use of ibuprofen and asks for an analysis across Europe

French Medicines Agency (ANSM) issued a warning to doctors and patients after detect the risks badociated with the use of two drugs: ibuprofen and ketoprofen. Both are nonsteroidal anti-inflammatory drugs that produce badgesic effects.

The study determined that there is a series of infections, especially those caused by streptococcus, this could worsen after ingestion of these medications. According to specialists, rhinopharyngitis; otitis; The lung infection and skin lesions could worsen with these drugs.

For the agency, the problem is not minor, because in France, ibuprofen It's one of the most used pain relieverswhy the experts determined that this was a "first level of seriousness" situation. The study was conducted in the regional centers of Tours and Marseille of the National Agency for Safety of Medicines and Health Products (ANSM).

The worsening of the clinical picture was observed after very short periods of treatment (between two and three days), when ibuprofen or ketoprofen had been prescribed fever, benign skin problems of inflammatory appearance, respiratory diseases or the ear, nose and throat system.

Given the results obtained, the agency requested that an badysis be conducted with other European organizations to further evaluate the risk / benefit ratio of these products.

So far, 337 cases of complications have been badyzed with ibuprofen infections and 49 with ketoprofen.